RCEL financials
Avita Medical (RCEL) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RCEL income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $71.61M | $58.82M | -$42.53M | -$48.59M | -1.74 |
| 2024 | $64.25M | $55.16M | -$56.59M | -$61.84M | -2.39 |
| 2023 | $50.14M | $42.36M | -$42.66M | -$35.38M | -1.40 |
| 2022 | $34.42M | $28.38M | -$27.50M | -$26.66M | -1.07 |
| 2021 | $33.02M | $26.92M | -$25.12M | -$25.14M | -1.03 |
| 2020 | $29.23M | $23.28M | -$26.54M | -$26.58M | -1.17 |
- RCEL revenue was $71.61M in fiscal 2025, net income -$48.59M.
Updated 2026-11-06 11:42 UTC